Many women with UC who underwent IPAA maintain stable pouch function in pregnancy, though pouchitis can occur and requires monitoring.

Oral semaglutide reduces risk for heart failure (HF) events among patients with preexisting HF, according to study findings published in JAMA Internal Medicine. The SOUL trial (Cl ...

Compared with usual care, an activity-tracking-supported energy management intervention does not reduce the frequency or severity of postexertional malaise in people with long COVID.

Prepregnancy parental obesity significantly increased risk for metabolic dysfunction-associated steatotic liver disease in offspring.

Among youth aged 12 to 17 years with BMI in at least the 95th percentile for age and sex, 20% had 1 or more GLP-1 RA prescriptions.

A new predictive model using common lab values demonstrated high accuracy in detecting MetALD-ALD in patients with obesity.

Robert F. Kennedy Jr announced a federal initiative in which 53 medical schools agreed to increase student nutrition education to 40 hours.

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

The table below is a review of notable updates that occurred in February 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Trader Joe’s and Ajinomoto Foods voluntarily recalled frozen meals nationwide after multiple consumer complaints about glass in the products.

Risankizumab showed high rates of clinical remission and endoscopic response when administered as subcutaneous induction therapy for moderate to severe CD.

Earlier antiviral treatment in children with chronic hepatitis B is linked to faster viral clearance and improved long-term liver outcomes.